Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:20 PM
Ignite Modification Date:
2026-03-26 @ 3:20 PM
NCT ID:
NCT07404605
Eligibility Criteria:
Inclusion Criteria:
* Adults aged 18 years or older
* Histologically confirmed cutaneous melanoma
* Presence of cutaneous and/or subcutaneous metastases eligible for electrochemotherapy
* Candidate for electrochemotherapy with intravenous bleomycin or intratumoral cisplatin according to standard clinical practice
* Ability to provide written informed consent
Exclusion Criteria:
* Contraindication to electrochemotherapy or study drugs (bleomycin or cisplatin)
* Pregnancy or breastfeeding
* Severe comorbidities preventing electrochemotherapy
* Inability to comply with study procedures
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07404605
Study Brief:
Protocol Section:
NCT07404605